Navigation Links
Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
Date:9/18/2012

BALA CYNWYD, Pa., Sept. 18, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Complete Genomics, Inc. ("Genomics" or the "Company") (Nasdaq:  GNOM) relating to the proposed acquisition by BGI-Shenzhen. ("BGI").

Under the terms of the transaction, Genomics shareholders will receive only $3.15 in cash for each share of Genomics stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Genomics for not acting in the Company's shareholders' best interests in connection with the sale process to BGI. The transaction may undervalue the Company as Genomics stock traded at $7.13 a share on September 19, 2011 and at $4.12 as recently as March 5, 2012. In addition, an analyst has placed a price target on Genomics stock at $5.00 per share.

If you own shares of Genomics stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/477-gnom-complete-genomics-inc.html by calling toll free 877-LEGAL-90.


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
10. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2020)... ... March 12, 2020 , ... With the ... technology, increases the business investment in Europe by inaugurating a new scientific facility ... Ceremony of the new Nanoscience Center Europe took place Tuesday, February 18, 2020, ...
(Date:3/10/2020)... ... , ... Lifecycle Biotechnologies announced today that is has acquired a ... as a biopharmaceutical and biotechnology production and development campus. Lifecycle is currently updating the ... production and development hub. The company expects to relocate from Fort Worth, Texas by ...
(Date:3/3/2020)... Ill. (PRWEB) , ... March 03, 2020 , ... ... company serving the pharmaceutical, biotech and medical device industries, was recognized by INC. ... 5,000 puts forward annual lists to note industry leaders greatly impacting their spheres ...
(Date:2/28/2020)... ... February 26, 2020 , ... Designed primarily for laboratory and ... dedicated controller, thus simplifying setup, streamlining integration, and optimizing workflow. Capable of recording ... Fastec Imaging’s new HS Series cameras to be released. The HS Series includes ...
Breaking Biology Technology:
(Date:3/11/2020)... , ... March 11, 2020 , ... ... wireless sensing, today announced smart human body temperature infrared touch-free monitoring product family, ... thermal meter WxS x800-IRTM, supporting flexible wireless uplink for cloud connectivity such as ...
(Date:3/9/2020)... ... March 09, 2020 , ... ... 64% last year, as enterprises sought to achieve competitive advantage by transforming ... 13% of all transformation efforts delivered the intended consequences. , Application transformation ...
(Date:3/5/2020)... ... March 05, 2020 , ... Cytonus ... comprised of the industry’s key opinion leaders and distinguished research scientists, collectively ... Cytonus is a leading cell-based platform technology company focused on the development ...
Breaking Biology News(10 mins):